Canopy Health Innovations (Canopy Health) is committed to understanding the therapeutic potential of cannabis. Through our research programs, our aim is to create natural plant-based medicines and health products derived from cannabis to improve the quality of life for those affected by acute and chronic illness. Our primary research area is within neuroscience.
We aim to support applicants who are rigorous with their research and committed to advancing cannabinoid science. If you would like to collaborate with us, please complete the request for an Investigator Initiated Research Initial Application (IIR-A). We appreciate your interest and look forward to reviewing the submission.
Canopy Health may support projects financially or through product provision, including placebo material, so long as the proposed request meets the following guidelines:
Canopy Health will not consider requests for the following activities:
To determine eligibility, a request for an IIR-A must be completed and submitted. It is important that the IIR-A and request not include any sensitive or confidential information. Should the IIR-A be accepted, a Mutual Confidentiality Agreement or Non-Disclosure Agreement will be put in place for subsequent discussions and submissions, including the IIR Full Submission (IIR-B).
Proposed projects, investigators, and team members must meet the following criteria for eligibility:
IIR studies operate independently of Canopy Health and its associated companies. Canopy Health will not solicit or instigate the application of IIR. No member of the Canopy Health team will direct the aims, hypotheses, design, or operational activities of the approved study. However, employees at Canopy Health and its associated companies (Canopy Growth Corporation and Canopy Animal Health) may comment on any aspect of the proposed study to ensure it is safe, based on sound principles, and has sufficient background literature to support its aims. The supply of Canopy Health products will be discussed prior to the study being approved, based on (and not exceeding) market value.
The applicant is responsible for all elements of the study, including but not limited to study design, execution, recruitment, meeting milestones, data gathering and analysis, and dissemination of the results. It is the responsibility of the PI to ensure that local laws, rules, and ethical regulations are followed during the study. It is the applicant’s responsibility to communicate the progress of the study on a mutually agreed upon schedule with Canopy Health.
It is expected that any research conducted with Canopy Health and its associated companies will:
Canopy Health retains the right to terminate a project at any time if there is deviation from the Study Protocol, Regulatory Documents, undisclosed elements of the study, or if the study does not comply with local regulations or laws.
Ensure the team or organization meet the Eligibility requirements and agree to the Expectations outlined above.
Complete the request for an IIR-A.
Canopy Health will send the IIR-A within 5-10 business days.
Follow the instructions to complete and submit the IIR-A.
If approved, Canopy-Health will be in contact to discuss the process for an IIR-B.
Complete and execute Confidentiality Agreements and/or Non-Disclosure Agreements.
Canopy Health will send guidelines for an IIR-B.
Follow the instructions to complete and submit the IIR-B.
Wait for feedback.
Should the application be accepted, Canopy-Health may request additional documents, including but not limited to a Research Collaboration Agreement.
Do not share any confidential or sensitive intellectual property information on this form. By completing this form, you agree to having read all sections under Research Collaboration and confirm that you, your team, institution, or organization are eligible and accept all expectations set out by Canopy Health.
The Canopy Health Scientific Advisory Board will review the submission and send the IIR-A within 5-10 business days.